Tango Therapeutics, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Tango Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q2 2024.
Tango Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 55.4 %, a 26.1% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	55.4	-19.5	-26.1%	Jun 30, 2024
Q1 2024	60.5	-6.68	-9.95%	Mar 31, 2024
Q4 2023	66.4	+6.92	+11.6%	Dec 31, 2023
Q3 2023	70.5	+18.2	+34.8%	Sep 30, 2023
Q2 2023	74.9	+28.2	+60.3%	Jun 30, 2023
Q1 2023	67.2	+23.2	+52.7%	Mar 31, 2023
Q4 2022	59.5	+19.1	+47.2%	Dec 31, 2022
Q3 2022	52.3	-14.6	-21.8%	Sep 30, 2022
Q2 2022	46.7	-47.6	-50.4%	Jun 30, 2022
Q1 2022	44			Mar 31, 2022
Q4 2021	40.4			Dec 31, 2021
Q3 2021	66.9			Sep 30, 2021
Q2 2021	94.3			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.